Evidence map›Paper›PMID 35372453›Full record

ArticleFrontiers in medicine2022

Prolonged Shedding of SARS-CoV-2 in Feces of COVID-19 Positive Patients: Trends in Genomic Variation in First and Second Wave.

Mallika Lavania, Madhuri S Joshi, Sujata S Ranshing, Varsha A Potdar, Manohar Shinde, Nutan Chavan, Santosh M Jadhav, Prasad Sarkale, Sreelekshmy Mohandas, Pradeep M Sawant and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Resurrecting Epstein-Barr Virus.Pathogens (Basel, Switzerland) · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Mallika LavaniaEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Madhuri S JoshiEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Sujata S RanshingEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Varsha A PotdarNational Influenza Centre, ICMR-National Institute of Virology, Pune, India.
Manohar ShindeEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Nutan ChavanEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Santosh M JadhavBioinformatics and Data Management Group, ICMR-National Institute of Virology, Pune, India.
Prasad SarkaleMicrobial Containment Laboratory, ICMR-National Institute of Virology, Pune, India.
Sreelekshmy MohandasMicrobial Containment Laboratory, ICMR-National Institute of Virology, Pune, India.
Pradeep M SawantEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Sanjaykumar TikuteEnteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Vikram PadbidriMicrobiology and Infection Control Jehangir Hospital, Pune, India.
Sampada PatwardhanMicrobiology and Hospital Infection Control, Deenanath Mangeshkar Hospital and Research Center, Pune, India.
Rohan KateDepartment of Medicine, Lokmanya Hospital Chinchwad, Pune, India.
ICMR-National Institute of Virology · INDeenanath Mangeshkar Hospital and Research Center · INJehangir Hospital · INNiramaya Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main route of the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are through respiratory pathways and close contact of human-to-human. While information about other modes of transmission is comparatively less, some published literature supporting the likelihood of a fecal-oral mode of transmission has been accumulating. The diagnosis of SARS-COV-2 infected cases is based on the real-time reverse transcription-PCR (RT-PCR). The fecal excretion of SARS-COV-2 has been reported frequently, however, the role of fecal viral load with the severity of disease is not yet clear. Our study focused on the investigation of SARS-CoV-2 shedding in the fecal samples of patients with coronavirus disease 2019 (COVID-19). A total of 280 RT-PCR-positive patients were enrolled, among them 15.4% had gastrointestinal (GI) symptoms. It was shown that 62% of the patients were positive for SARS-CoV-2 RNA in fecal specimens. This positivity was not related to the presence of GI symptoms and the severity of disease. The next generation sequencing [NGS] of SARS-CoV-2 from fecal samples of patients was performed to analyze mutational variations. Findings from this study not only emphasized the potential presence of SARS-CoV-2 in feces, but also its continuing mutational changes and its possible role in fecal-oral transmission.

Indexed as

COVID-19fecalNGSreal time RT-PCRSARS-CoV-2

Identifiers

PMID35372453
PMCPMC8965355
OpenAlexW4221121057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.